Swiss open to compromise in Covid vaccine talks at WTO
Switzerland is open to compromise in talks on the intellectual property (IP) rights of Covid-19 vaccines and drugs at the World Trade Organization (WTO), but it remains opposed to a full waiver of those rights, says a senior Swiss diplomat.
This content was published on
2 minutes
Reuters/ts
Switzerland is one of a handful of WTO members alongside Britain and the European Union opposed to a waiver of IP rights protected by the TRIPS agreement in negotiations at the WTO that began in October 2020.
Proponents and activists are heaping pressure on those hold-out countries ahead of a ministerial conference in Geneva next week and plan to stage protests.
“We remain convinced that the TRIPS waiver will not result in one additional dose of vaccine and may jeopardise existing partnerships that have allowed us to increase production,” Didier Chambovey, Switzerland’s ambassador to the WTO, told reporters on Thursday.
However, he said the Swiss view was not “totally rigid” and that the country was in discussions with others about potentially finding agreement, without giving details of those discussions.
“We are really ready to look into this and to make a step in the direction of the other side,” Chambovey said.
Areas of compromise might involve simplifying the processes for compulsory licences and improving technology transfers, he said.
More
More
Swiss not swayed by US vaccine waiver announcement
This content was published on
Switzerland will “evaluate” the new proposition, but “many questions remain open”, the economics ministry said.
Activists say a waiver would help address vaccine inequity, noting that fewer than 7% of people in low-income countries had received a first Covid-19 shot and that supplies remained scarce.
Chambovey described this as a “real challenge” but said that removing patent protection would not solve this. He said difficulties with distribution, unfulfilled dose pledges, vaccine hoarding and poor health infrastructure in developing countries were to blame.
In his view, a more effective route is to use existing flexibilities in the TRIPS agreement that allow governments to issue “compulsory licences” to manufacturers.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Switzerland commits CHF50 million to combat rural poverty worldwide
This content was published on
The Federal Council approved a contribution of CHF49.5 million ($54.1 million) for the International Fund for Agricultural Development (IFAD).
Arrests made in raid against Turkish criminal organisation
This content was published on
A cross-border raid against a Turkish criminal organisation was conducted, including property searches in cantons Aargau and Zurich.
Up to 4,000 Swiss army soldiers to protect Ukraine peace conference
This content was published on
The Federal Council has authorised deployment of army personnel for the Ukraine peace conference on the Bürgenstock in June.
This content was published on
The business association, Swissmem, reports that there are increasing signs that the bottom of the downturn will be reached this year.
Calls intensify for Big Pharma to break monopolies on Covid-19 vaccines
This content was published on
Pressure is mounting to suspend intellectual property rules to help vaccines reach more people. Can the WTO find a solution?
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.